medroxyprogesterone acetate has been researched along with Hemorrhage in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dempsey, A; Roca, C; Westhoff, C | 1 |
| Bots, ML; Evans, GW; Grobbee, DE; Meijer, R; Störk, S | 1 |
| Mcdaniel, EB | 1 |
| D'arcangues, C | 1 |
| Ahmad, G; Rasul, A | 1 |
| Kistner, RW | 1 |
| Janaud, A | 1 |
| Correu Azcona, S | 1 |
| Jones, M | 1 |
| El-sokkary, H; Nayel, S; Toppozada, M; Tork, M | 1 |
| Shrestha, A; Stoeckel, J; Tuladhar, JM | 1 |
| Atabekoğlu, C; Cengiz, B; Cengiz, SD; Dökmeci, F; Sönmezer, M | 1 |
| Archer, DF; Chegini, N; Li, R; Luo, X | 1 |
| Bertaux, M; Boute, V; Brun, J; Galateau-Salle, F; Rigault, JY; Rigault-Guillemot, I | 1 |
| Ahomäki, SM; Heikkinen, JE; Kainulainen, PM; Timonen, UM; Vaheri, RT; Viitanen, AT | 1 |
| Cheung, MY; Ma, HK; Tang, LC | 1 |
3 trial(s) available for medroxyprogesterone acetate and Hemorrhage
| Article | Year |
|---|---|
Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial.
Topics: Administration, Intravaginal; Adult; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Estrogens; Female; Hemorrhage; Humans; Logistic Models; Medroxyprogesterone Acetate; Patient Satisfaction; Prospective Studies | 2010 |
Striking increases in carotid artery wall thickness in healthy subjects.
Topics: Carotid Arteries; Carotid Artery Diseases; Estrogens; Female; Follow-Up Studies; Hemorrhage; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Nonlinear Dynamics; Norpregnenes; Postmenopause; Time Factors; Tunica Intima; Tunica Media; Ultrasonography | 2010 |
Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens.
Topics: Bone Density; Climacteric; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Hemorrhage; Hormone Replacement Therapy; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners | 2000 |
15 other study(ies) available for medroxyprogesterone acetate and Hemorrhage
| Article | Year |
|---|---|
Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
Topics: Amenorrhea; Asia; Asia, Eastern; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Patient Acceptance of Health Care; Signs and Symptoms | 1980 |
Once-a-month estrogen/progestogen injectables.
Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization | 1991 |
Study of medroxyprogesterone: a long-acting injectable female contraceptive agent.
Topics: Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Genitalia; Genitalia, Female; Hemorrhage; Histology; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Parity; Physiology; Research; Signs and Symptoms; Urogenital System; Uterus | 1970 |
Pretreatment counseling keeps patients on Depo.
Topics: Ambulatory Care Facilities; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Economics; Family Planning Services; Health Planning; Health Services Needs and Demand; Hemorrhage; Injections; Medroxyprogesterone Acetate; Metrorrhagia; Organization and Administration; Physiology; Signs and Symptoms | 1997 |
Newer synthetic progestins for the treatment of endometriosis.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases | 1970 |
[Depo-provera as a long-term contraceptive].
Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Hemorrhage; Infertility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms | 1974 |
Three-monthly Depo-Provera in Mexico.
Topics: Amenorrhea; Appetite; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Digestive System; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms | 1977 |
Depo-Provera: just another contraceptive?
Topics: Amenorrhea; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; England; Europe; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Neoplasms; North America; Signs and Symptoms; United Kingdom; United States | 1978 |
Management of amenorrhea due to contraceptive injectables by temporary IUD insertion.
Topics: Age Factors; Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Diagnosis; Disease; Family Planning Services; Hemorrhage; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Patient Acceptance of Health Care; Retention, Psychology; Therapeutics | 1982 |
The KAP-gap in Nepal: reasons for non-use of contraception among couples with an unmet need for family planning.
Topics: Asia; Birth Intervals; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Diagnosis; Disease; Endoscopy; Family Planning Services; Headache; Health; Health Knowledge, Attitudes, Practice; Hemorrhage; Laparoscopy; Medroxyprogesterone Acetate; Nausea; Nepal; Nutritional Physiological Phenomena; Physical Examination; Research; Sampling Studies; Signs and Symptoms; Sterilization, Reproductive; Surveys and Questionnaires; Vasectomy | 1991 |
Medicolegal issues surrounding Depo-Provera easily overcome.
Topics: Americas; Consumer Product Safety; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developed Countries; Disease; Drug Prescriptions; Family Planning Services; Health; Health Personnel; Health Planning; Hemorrhage; Informed Consent; Legislation as Topic; Medroxyprogesterone Acetate; North America; Organization and Administration; Physicians; Signs and Symptoms; United States | 1992 |
Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum.
Topics: Adult; Anticoagulants; Contraceptive Agents; Corpus Luteum; Delayed-Action Preparations; Drug Interactions; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Probability; Prospective Studies; Risk Assessment; Treatment Outcome | 2005 |
RETRACTED: Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokine.
Topics: Anti-Bacterial Agents; Cell Line; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Doxycycline; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression Regulation, Enzymologic; Hemorrhage; Humans; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tumor Necrosis Factor-alpha | 2007 |
[Pulmonary involvement of Bourneville's tuberous sclerosis. The value of early detection. A familial form].
Topics: Adult; Female; Hemorrhage; Humans; Lung Diseases, Obstructive; Medroxyprogesterone Acetate; Middle Aged; Oxygen Inhalation Therapy; Pulmonary Alveoli; Respiratory Function Tests; Tamoxifen; Tomography, X-Ray Computed; Tuberous Sclerosis | 1993 |
Intraperitoneal bleeding from ectopic decidua following hormonal contraception. Case report.
Topics: Adult; Contraceptive Agents, Female; Decidua; Fallopian Tubes; Female; Hematocele; Hemorrhage; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pelvis | 1985 |